Genesco (GCO) to Announce Earnings on Thursday

Genesco (NYSE:GCO) is anticipated to post its Q2 2027 results before the market opens on Thursday, September 3rd. Analysts expect the company to post earnings of ($1.34) per share and revenue of $527.26 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q2 2027 earning summary page for the latest details on the call scheduled for Thursday, September 3, 2026 at 8:30 AM ET.

Genesco (NYSE:GCO) last announced its quarterly earnings results on Friday, May 29th. The company reported ($2.18) EPS for the quarter, beating the consensus estimate of ($2.58) by $0.40. Genesco had a net margin of 0.80% and a return on equity of 2.66%. The firm had revenue of $487.03 million during the quarter, compared to the consensus estimate of $474.32 million. On average, analysts expect Genesco to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Genesco Stock Up 0.2%

Shares of NYSE GCO opened at $33.38 on Tuesday. The company has a current ratio of 1.83, a quick ratio of 0.37 and a debt-to-equity ratio of 0.08. Genesco has a 12 month low of $21.92 and a 12 month high of $43.60. The firm has a market capitalization of $370.85 million, a price-to-earnings ratio of 19.29 and a beta of 1.83. The business has a 50-day moving average of $35.55 and a 200-day moving average of $33.23.

Insider Buying and Selling

In other news, Director Gregory A. Sandfort purchased 2,958 shares of the business’s stock in a transaction on Thursday, July 9th. The stock was acquired at an average price of $33.80 per share, for a total transaction of $99,980.40. Following the acquisition, the director directly owned 29,172 shares of the company’s stock, valued at $986,013.60. This represents a 11.28% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 23.11% of the company’s stock.

Institutional Trading of Genesco

Several hedge funds have recently made changes to their positions in the business. Fund 1 Investments LLC raised its position in Genesco by 3.5% during the fourth quarter. Fund 1 Investments LLC now owns 986,241 shares of the company’s stock valued at $24,429,000 after purchasing an additional 33,044 shares during the period. Charles Schwab Investment Management Inc. boosted its position in Genesco by 23.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 409,227 shares of the company’s stock valued at $10,137,000 after buying an additional 76,494 shares during the period. Healthcare of Ontario Pension Plan Trust Fund grew its stake in Genesco by 50.0% in the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 300,000 shares of the company’s stock worth $7,431,000 after purchasing an additional 100,000 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its position in shares of Genesco by 6.7% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 290,639 shares of the company’s stock worth $8,426,000 after buying an additional 18,184 shares in the last quarter. Finally, Bridgeway Capital Management LLC increased its position in Genesco by 29.7% during the 2nd quarter. Bridgeway Capital Management LLC now owns 238,252 shares of the company’s stock valued at $4,691,000 after purchasing an additional 54,498 shares during the period. 94.51% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on GCO shares. Zacks Research downgraded Genesco from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 31st. Wall Street Zen downgraded Genesco from a “buy” rating to a “hold” rating in a report on Saturday, June 13th. Weiss Ratings lowered shares of Genesco from a “hold (c)” rating to a “sell (d+)” rating in a research note on Friday, June 12th. Seaport Research Partners cut Genesco from a “buy” rating to a “neutral” rating in a research note on Wednesday, May 27th. Finally, Truist Financial set a $40.00 target price on shares of Genesco in a report on Friday, May 29th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $36.67.

About Genesco

Genesco Inc is a Nashville, Tennessee-based retailer, wholesaler and licensee specializing in branded footwear, headwear, apparel and accessories. Through its portfolio of retail chains, wholesale distribution channels and licensing agreements, Genesco brings a range of product offerings to consumers in North America and Europe.

The company’s retail segment includes specialty chains such as Journeys, which targets fashion-focused teens and young adults in the United States and Canada, and Schuh, a footwear retailer with locations in the United Kingdom and Ireland.